NO864369L - Polypeptider som er komplementaere til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent. - Google Patents

Polypeptider som er komplementaere til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent.

Info

Publication number
NO864369L
NO864369L NO86864369A NO864369A NO864369L NO 864369 L NO864369 L NO 864369L NO 86864369 A NO86864369 A NO 86864369A NO 864369 A NO864369 A NO 864369A NO 864369 L NO864369 L NO 864369L
Authority
NO
Norway
Prior art keywords
peptides
proteins
amino acid
acid sequence
nucleotide coding
Prior art date
Application number
NO86864369A
Other languages
English (en)
Other versions
NO174971C (no
NO174971B (no
NO864369D0 (no
Inventor
J Edwin Blalock
Kenneth L Bost
Eric M Smith
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO864369D0 publication Critical patent/NO864369D0/no
Publication of NO864369L publication Critical patent/NO864369L/no
Publication of NO174971B publication Critical patent/NO174971B/no
Publication of NO174971C publication Critical patent/NO174971C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO864369A 1985-03-01 1986-10-31 Fremgangsmåter for bestemmelse av polypetider som er komplementære til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent NO174971C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
PCT/US1986/000353 WO1986005208A1 (en) 1985-03-01 1986-02-24 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (4)

Publication Number Publication Date
NO864369D0 NO864369D0 (no) 1986-10-31
NO864369L true NO864369L (no) 1987-01-02
NO174971B NO174971B (no) 1994-05-02
NO174971C NO174971C (no) 1994-08-10

Family

ID=27108003

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864369A NO174971C (no) 1985-03-01 1986-10-31 Fremgangsmåter for bestemmelse av polypetider som er komplementære til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent

Country Status (18)

Country Link
US (2) US5077195A (no)
EP (2) EP0332225B1 (no)
JP (1) JPH07215999A (no)
KR (1) KR920002315B1 (no)
AT (2) ATE88572T1 (no)
AU (1) AU592781B2 (no)
BR (1) BR8606615A (no)
CA (1) CA1339606C (no)
DE (2) DE3688333T2 (no)
DK (1) DK521386A (no)
ES (3) ES8705919A1 (no)
FI (1) FI90255C (no)
GR (1) GR860576B (no)
IE (1) IE58837B1 (no)
IL (1) IL96043A0 (no)
NO (1) NO174971C (no)
PT (1) PT82132B (no)
WO (1) WO1986005208A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199801B1 (en) * 1984-10-29 1993-08-25 MICROGENICS CORPORATION (a Delaware corporation) Methods for protein binding enzyme complementation assays
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
AU595597B2 (en) * 1986-02-19 1990-04-05 Triton Biosciences Inc. Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
EP0331184A3 (en) * 1988-03-04 1991-05-08 The Board Of Trustees Of The University Of Alabama For Its Division University Of Alabama In Birmingham Peptide equivalents of non-peptides and methods of design therefor
DE69033395D1 (de) * 1989-07-31 2000-01-20 Tecnogen Scpa Verfahren zur Identifizierung und Herstellung von Bindungsstellen aufeinanderwirkender Proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
JP3923515B2 (ja) * 1993-10-07 2007-06-06 倉敷紡績株式会社 エンドセリン活性抑制剤
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
DE69627333T2 (de) * 1995-06-26 2004-02-12 PerSeptive Biosystems, Inc., Framingham Automatisierte, kontinuierliche mehrdimensionale hochgeschwindigkeitsmolekularselektion und -analyse
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
AU756139B2 (en) * 1997-12-01 2003-01-02 Fang Fang Multivalent recombinant antibodies for treating HRV infections
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
CA2350163A1 (en) * 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
ATE411811T1 (de) * 1999-03-09 2008-11-15 Fornix Biosciences N V Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie
GB2356401A (en) * 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
WO2002027313A1 (en) * 2000-09-26 2002-04-04 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
EP1362093B1 (en) * 2001-02-20 2010-11-17 University Of Georgia Research Foundation, Inc. Rapid production of monoclonal antibodies
JP2005522192A (ja) * 2001-07-19 2005-07-28 パーラン セラピューティクス， インコーポレイテッド マルチマータンパク質およびマルチマータンパク質を作製および使用する方法
RU2519210C2 (ru) * 2007-06-14 2014-06-10 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Вакцины, содержащие генетические варианты парвовируса собак
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
JPH07215999A (ja) 1995-08-15
DE3679017D1 (de) 1991-06-06
CA1339606C (en) 1997-12-30
GR860576B (en) 1986-07-01
DE3688333D1 (de) 1993-05-27
US5077195A (en) 1991-12-31
ES552534A0 (es) 1987-05-16
FI90255B (fi) 1993-09-30
EP0214232A1 (en) 1987-03-18
PT82132B (pt) 1989-05-31
DE3688333T2 (de) 1993-10-28
ATE88572T1 (de) 1993-05-15
EP0214232B1 (en) 1991-05-02
AU5510286A (en) 1986-09-24
FI90255C (fi) 1994-01-10
DK521386D0 (da) 1986-10-31
US5212072A (en) 1993-05-18
WO1986005208A1 (en) 1986-09-12
EP0332225A2 (en) 1989-09-13
AU592781B2 (en) 1990-01-25
EP0332225A3 (en) 1989-09-27
IL96043A0 (en) 1991-07-18
ES557189A0 (es) 1987-11-01
IE860527L (en) 1986-09-01
ES8800266A1 (es) 1987-11-01
IE58837B1 (en) 1993-11-17
KR870700100A (ko) 1987-02-28
ES8705919A1 (es) 1987-05-16
BR8606615A (pt) 1987-08-11
NO174971C (no) 1994-08-10
DK521386A (da) 1986-12-29
PT82132A (en) 1986-04-01
EP0332225B1 (en) 1993-04-21
FI864427A0 (fi) 1986-10-30
ATE63138T1 (de) 1991-05-15
KR920002315B1 (ko) 1992-03-21
ES557188A0 (es) 1987-11-01
ES8800267A1 (es) 1987-11-01
FI864427A (fi) 1986-10-30
NO174971B (no) 1994-05-02
NO864369D0 (no) 1986-10-31

Similar Documents

Publication Publication Date Title
NO864369L (no) Polypeptider som er komplementaere til peptider eller proteiner som har en aminosyresekvens eller en nukleotidkodende sekvens som er minst delvis kjent.
DE3587814D1 (de) Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren.
DE3856560D1 (de) Dem menschlichen gewebefaktor ähnliche dns-segmente, polypeptide und antikörper
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
ATE189684T1 (de) Rekombinante polypeptide und peptide, dafür kodierende nukleinsäuren und ihre verwendung in der tuberkulose-diagnose
Benjamini et al. Immunochemical studies on the tobacco mosaic virus protein. I. The immunological relationship of the tryptic peptides of tobacco mosaic virus protein to the whole protein
DK150992A (da) Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
DE3587840D1 (de) Für das Polypeptid des T-Zellantigenreceptors kodierende Nukleinsäure.
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
ZA861482B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
JPS646219A (en) Peptide having promoting action on activation of protein c by thrombin
ATE301712T1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
Schalekamp et al. Recombination of embryonic haemoglobin chains during the development of the chick
ATE317851T1 (de) Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie
HU214696B (hu) Eljárás libák és barbari kacsák parvovírusos megbetegedése elleni rekombináns vakcina és immunvizsgálati készlet előállítására
IL96043A (en) Polypeptides having binding affinity for peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known,the binding affinity being dependent on the carboxy-terminal and amino-terminal directionality of the polypeptides
NO871737D0 (no) Rekombinant virus, polypeptid samt dna molekyl med kodingssekvens for dette polypeptid.
BR9812609A (pt) Sequência nucleotìdica, polipeptìdeo, utilização de um polipeptìdeo, processos de preparação de um polipeptìdeo e de evidenciamento ou de isolamento de compostos capazes de modular ou de inibir a interação entre as presenilinas e os polipeptìdeos, célula hospedeira para a produção de polipeptìdeo, oligonucleotìdeo anti-sentido, sonda nucleotìdica, anticorpo ou fragmento de anticorpo, ligante de um polipeptìdeo, utilização de um ligante, vìrus recombinante defectivo, vetor, e, composição farmacêutica